José Del Río Pantoja is a PhD candidate in chemical biology at Harvard Griffin GSAS. A member of the Mostoslavsky Lab at Massachusetts General Hospital, he is challenging long-held assumptions about the way proteins are formed in cells—and uncovering how missteps in that process may underlie disease. Del Río Pantoja reflects on his unexpected path to a PhD, the mentors who shaped his journey, and the power of rest in scientific discovery.
NY Times - Progress in the quest to help progeria patients suggests that gene editing techniques from David Liu's lab may help treat other ultrarare conditions